Joseph E. Glass, PhD, MSW

Glass_Joseph_E_205x287.jpg

“We need to increase the reach of addiction treatment within health care systems. Many more people could benefit from effective care.”

Joseph E. Glass, PhD, MSW

Senior Scientific Investigator, Kaiser Permanente Washington Health Research Institute
Affiliate Associate Professor, Department of Health Systems and Population Health, Department of Psychiatry and Behavioral Sciences, University of Washington

Biography

Joseph Glass, PhD, MSW, is an associate investigator at Kaiser Permanente Washington Health Research Institute (KPWHRI). Before joining KPWHRI in July 2016, he was an assistant professor at the University of Wisconsin–Madison School of Social Work.

Dr. Glass’s research seeks to identify how effective health care interventions for unhealthy alcohol and drug use can reach more people. Much of his work aims to develop, test, and implement modern models of care that proactively deliver evidence-based treatments within health care settings and that intensively refer patients to specialty care while considering social determinants of health.

Dr. Glass’s work is informed by his practical experience in the field. After receiving a Master of Social Work from the University of Michigan, Dr. Glass was a psychiatric social worker at the Veterans Affairs Ann Arbor Healthcare System. There he developed expertise in social work case management and evidence-based treatments for anxiety, depression, and substance use disorders.

He completed a 5-year career development award funded by the National Institute on Alcohol Abuse and Alcoholism in 2021, which allowed him to obtain intensive training in clinical trials and implementation science. Currently, he has 2 active randomized controlled trials.

  • One is a 5-year grant awarded by the National Institute on Drug Abuse called the DIGITS Trial, which is testing strategies for improving how clinicians and patients use app-based treatments for substance use disorder in primary care.
  • Another study is the Addressing Barriers to Care Trial (ABC-SUD), which is a 5-year grant awarded by the National Institute on Drug Abuse as part of the Center for Dissemination and Implementation Science at Stanford. The ABC-SUD study is evaluating use of Care Navigators to improve the rate at which people successfully obtain treatment when they are referred to care.

Dr. Glass also co-leads a 2-year study funded by the National Institute on Alcohol Abuse and Alcoholism to validate and improve approaches for monitoring the quality of care for alcohol use disorder. He also enjoys serving as a co-investigator and consultant, providing expertise and support to studies led by his colleagues.

Dr. Glass is an affiliate associate professor of health systems and population health, and of psychiatry and behavioral sciences, at the University of Washington.​​​​​

Research interests and experience


Sparc trial tools

Resources for behavioral health integration

The SPARC trial successfully implemented behavioral health care into primary care. On our website, you can access tools for behavioral health integration, as well as frequently asked questions and publications.


Recent publications

Oh BH, Glass J, Narita Z, Koyanagi A, Sinha S, Jacob L. Discrimination and multimorbidity among Black Americans: findings from the National Survey of American Life. J Racial Ethn Health Disparities. 2020 May 26. doi: 10.1007/s40615-020-00773-z. [Epub ahead of print]. PubMed

Fortuna KL, Muralidharan A, Goldstein CM, Venegas M, Glass JE, Brooks JM. Certified peer specialists' perspective of the barriers and facilitators to mobile health engagement.  J Technol Behav Sci. 2020;5(4):318-323. doi: 10.1007/s41347-020-00138-7. Epub 2020 Apr 27.  PubMed

Richards JE, Shortreed SM, Simon GE, Penfold RB, Glass JE, Ziebell R, Williams EC. Association between patterns of alcohol use and short-term risk of suicide attempt among patients with and without reported suicidal ideation. J Addict Med. 2020 Mar 5. doi: 10.1097/ADM.0000000000000637. [Epub ahead of print]. PubMed

Boudreau DM, Lapham G, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Campbell CI, Rossom RC, Binswanger IA, Yarborough BJH, Arnsten JH, Cunningham CO, Glass JE, Murphy MT, Zare M, Hechter R, Ahmedani B, Braciszewski JM, Horigian VE, Szapocznik J, Samet JH, Saxon AJ, Schwartz RP, Bradley KA. Documented opioid use disorder and its treatment in primary care patients across six US health systems. J Subst Abuse Treat. 2020 Mar;112S:41-48. doi: 10.1016/j.jsat.2020.02.001. PubMed

Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, Liu D, Samet JH, Saxon AJ, Campbell CI, Glass JE, Rossom RC, Murphy MT, Binswanger IA, Yarborough BJH, Bradley KA. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.  Drug Alcohol Depend. 2020;207:107732. doi: 10.1016/j.drugalcdep.2019.107732. Epub 2019 Nov 15.  PubMed

 

Healthy Findings Blog

ABC-Study_JoeGlass_QA_1col.jpg

Understanding the needs of people seeking care for substance use

Joe Glass explores how to engage patients with treatment for alcohol or drug use.

Research

PROUD_trial_1col.jpg

Increasing opioid use disorder treatment in primary care

A trial led by KPWHRI researchers found that adding nurse care managers helped more people get needed treatment.

Research

SPARC-study_story_blog_1col.jpg

Better care for patients who drink alcohol

A new primary care approach improves alcohol-related preventive care as well as care for alcohol use disorder.